Tirzepatide is a dual GIP/GLP-1 receptor agonist — a novel synthetic peptide in the incretin mimetic class. Studied in laboratory settings for its interactions with both GIP and GLP-1 receptor pathways. Available as lyophilised powder.
| Vial Size | 5mg |
| Purity | ≥99% (HPLC verified) |
| Molecular Weight | 4813.5 g/mol |
| CAS Number | 2023788-19-2 |
| Appearance | White lyophilised powder |
| Storage | -20°C (long-term) / 4°C (short-term) |
| Certification | GMP Certified |
Send us a message and we'll confirm pricing, availability, and shipping details.
Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It represents a novel class of research compounds — incretin mimetics that target two receptors simultaneously.
Research interest in Tirzepatide has focused on its interactions with incretin receptor signalling pathways in cell culture and animal models of metabolic biology.
Papa Peptides stocks Tirzepatide as a research-grade, lyophilised compound independently verified for purity and identity per batch.
| Peptide Name | Tirzepatide (dual GIP/GLP-1 agonist) |
| Purity | ≥99% by HPLC |
| Molecular Weight | 4813.5 g/mol |
| CAS Number | 2023788-19-2 |
| Appearance | White lyophilised powder |
| Vial Size | 5mg sterile vial |
| Manufacturing | GMP Certified via SPPS |
| Testing | Independent third-party COA per batch |
Lyophilised: Store at -20°C. Protect from light and moisture.
After reconstitution: Store at 4°C. Use within 3–4 weeks. Do not freeze reconstituted solution. Avoid repeated freeze-thaw cycles.
Use bacteriostatic water. Add solvent slowly. Swirl gently.
Message us on Telegram and we'll confirm pricing and availability.
✈️ Order via Telegram